DCs capture necrotic tumor cells, migrate to lymph nodes, and present tumor antigens (TAs) to naïve CD4+ T cells leading to their differentiation in effector CD4+ T cells, development of TA-specific CD8+ T cells, and their expansion. Here, CD8A is linked to neoplasm.